1-15 of 15
Keywords: Phase II study
Close
Sort by
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1996) 19 (4): 328–332.
Published Online: 12 May 2009
... and human tumor models. In a preceding Phase I study myelosuppression with predominant thrombocytopenia was the dose-limiting toxicity. Besides nausea and vomiting no further side effects were observed. Patients and Methods: The phase II study group of the AIO performed a phase II study in pretreated...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1994) 17 (1): 86–90.
Published Online: 08 May 2009
... Phase II study Taxol LAUFENDE KLINISCHE STUDIEN ONGOING CLINICAL TRIALS Onkologie 1994;17:86-90 U. Klaassen2 K. Diergarten C. H. Dittrich J. K aufm ann C. H. Sauter S. Seeber Randomized Trial of Two Doses of Taxol in Metastatic Breast Cancer: An Interim Analysis1 Innere Klinik und Poliklinik (Tum...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (1992) 15 (6): 465–469.
Published Online: 29 April 2009
... was observed in malignant melanoma, so that a disease-oriented phase II study was started. Material and Methods: 43 patients with advanced and progressive malignant melanoma were treated with the alkyllysophospholipid ilmofosine. Patients with and without pretreatment received 75 mg ilmofosine tablets t.i.d...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Onkologie
Onkologie (2009) 32 (4): 162–166.
Published Online: 13 March 2009
..., for most of these patients treatment options are limited, and no standard first-line regimen has been identified. We performed a phase II study with oxaliplatin (OX) and capecitabine (CAP) as first-line treatment for patients with histo-or cytologically proven adeno- or undifferentiated CUP. Patients...